Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1Sanofi
01 1CHLORPROMAZINE HYDROCHLORIDE
01 1France
01 1Active
01 1Complete
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : Complete
Rev. Date : 2013-06-03
Pay. Date : 2013-02-13
DMF Number : 1516
Submission : 1970-04-23
Status : Active
Type : II
20
Sanofi Winthrop Industrie, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is CHLORPROMAZINE HYDROCHLORIDE, with a corresponding US DMF Number 1516.
Remarkably, this DMF maintains an Active status since its submission on April 23, 1970, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 03, 2013, and payment made on February 13, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
